Takeda is a global research-based group focusing on pharmaceutical drugs.
The combined group companies have active commercial presence in the areas of metabolic diseases, gastroenterology, oncology, cardiovascular health, CNS diseases, inflammatory and immune disorders, respiratory diseases and pain management.
Since its founding over 230 years ago in Osaka, Japan, the company has set out on a trajectory to deliver medicines with unmet medical needs, adapting and changing to the times along the way.
Takeda is the largest Pharma company in Asia and is ranked number 12 globally.
The network of the Takeda group spans over 70 countries and regions worldwide, in Japan, the United States, Europe, Latin America, Africa, the Middle East, and the Asia Pacific Region.
Takeda|s pharmaceutical products are marketed in around 100 countries worldwide, including partnerships (marketing alliance partners).
As the largest pharmaceutical company in Japan and a global industry leader, Takeda is committed to striving towards better health for patients around the world through innovation in medicine. For additional information on Takeda, visit www.takeda.com.